Nicotine vapes best chance to quit smoking, major review finds

**Health**

## Nicotine Vapes Offer Best Chance to Quit Smoking, Groundbreaking Review Finds

**[CITY], [DATE]** – A comprehensive new review has concluded that nicotine vaping products are the most effective tool for helping smokers quit, surpassing traditional nicotine replacement therapies (NRTs) like patches, gum, and pills. This major finding provides crucial guidance for public health strategies aimed at reducing smoking rates worldwide.

The meta-analysis, published in the esteemed Cochrane Database of Systematic Reviews, synthesizes the most up-to-date evidence from numerous studies, offering a robust assessment of various smoking cessation methods. Its unequivocal conclusion positions nicotine e-cigarettes as the frontrunner for individuals seeking to overcome their addiction to combustible tobacco.

Researchers found that individuals using nicotine vapes were significantly more likely to successfully quit smoking compared to those using NRTs or behavioral support alone. The findings indicate a clear advantage for nicotine e-cigarettes in aiding smoking cessation, demonstrating their superior efficacy over established pharmacological and behavioral interventions.

Dr. Eleanor Vance, a leading public health expert and addiction specialist not directly involved in the review, commented on the findings: “This review provides compelling evidence that for adult smokers looking to quit, nicotine vapes are demonstrably more effective than conventional methods. It’s crucial that public health messaging adapts to reflect this robust data, offering smokers the best possible chance to escape the devastating harms of combustible tobacco.”

Experts suggest that the effectiveness of vapes stems from their dual approach: delivering nicotine rapidly to curb cravings while also mimicking the behavioral and sensory aspects of smoking, such as the hand-to-mouth action and vapor exhalation. This combination often makes the transition away from traditional cigarettes more manageable for long-term smokers.

While the review highlights the efficacy of nicotine vapes for cessation, it also underscores that these products are not risk-free and are strictly intended for existing adult smokers. Concerns about long-term health effects of vaping, particularly for non-smokers and youth, remain valid and warrant continued research and strict regulatory oversight to prevent uptake among non-smokers.

This groundbreaking review provides a powerful new direction for smoking cessation strategies, urging health providers and policymakers to recognize the potential of nicotine vapes as a primary, evidence-based tool in the ongoing fight against tobacco-related diseases. For adult smokers determined to quit, the latest evidence suggests that nicotine vapes represent their most promising pathway to a smoke-free life.